Health

#SFHS2615030AFrance Updates Labels for Reimbursable Medicines

🇫🇷France··Other·Low Impact·View source ↗

AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.

🇬🇧 English

This order updates the official reimbursement list for several medicines by changing their listed product descriptions, mainly the named laboratories attached to existing products. The affected medicines include CEGFILA, ENBREL and FIXICAL products, with the same CIP codes kept in place. The change matters mainly for pharmacies, wholesalers, health insurers and pharmaceutical companies that rely on the official reimbursement list for dispensing, billing and product records. It does not appear to add new reimbursement rights or change patient eligibility; it is a routine administrative update to product listings.

AI-generated summary. May contain errors. Refer to official sources for legal decisions.

Key Changes

  • Updates 19 product labels in the list of medicines reimbursable under French social security.
  • Changes the listed laboratory names for several existing products, including CEGFILA, ENBREL and FIXICAL.
  • Keeps the same CIP product codes, indicating record updates rather than new product entries.

Obligations

What this law requires

low

Update reimbursement-list product records so that CEGFILA 6 mg, CIP 34009 302 020 2 9, is listed with Laboratoires MUNDIPHARMA SAS instead of Laboratoires BIOGARAN.

pharmaciespharmaceutical wholesalershealth insurerspharmaceutical companies maintaining reimbursement records
operational
low

Update reimbursement-list product records so that ENBREL products with CIP codes 34009 216 763 2 7, 34009 360 649 9 7, 34009 377 191 0 0, 34009 301 110 1 7, 34009 377 195 6 8, and 34009 396 052 2 7 are listed with Laboratoires TEVA SANTE instead of Laboratoires PFIZER.

pharmaciespharmaceutical wholesalershealth insurerspharmaceutical companies maintaining reimbursement records
operational
low

Use the amended product descriptions in the official list of reimbursable pharmaceutical specialties for the affected medicines while keeping the same CIP codes.

Pharmacies, wholesalers, health insurers, and pharmaceutical companies using the French reimbursement list
operational
low

Record CEGFILA 6 mg under CIP code 34009 302 020 2 9 with Laboratoires MUNDIPHARMA SAS replacing Laboratoires BIOGARAN in the reimbursable medicines list.

Entities maintaining or using French reimbursable medicine product records
operational
low

Record the listed ENBREL presentations under their existing CIP codes with Laboratoires TEVA SANTE replacing Laboratoires PFIZER in the reimbursable medicines list.

Entities maintaining or using French reimbursable medicine product records
operational

Affected Parties

pharmacieshealth insurers+3 more…

Tags

pharmaceuticals,medicine reimbursement,France